Miao Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Miao Liu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ning Zhang
Department of Orthodontics, School of Stomatology, Capital Medical University, Beijing, China
3 shared publications Ce Bian
Department of Orthodontics, Beijing Stomatological Hospital and School of Stomatology, Capital MedicalUniversity, No.9 Fanjiacun Road, Fengtai District, Beijing, 100070, China
2 shared publications- Ce Bian
Department of Orthodontics, School of Stomatology, Capital Medical University, Beijing, China
1 shared publication Chengjun Su
Department of Orthodontics, Beijing Stomatological Hospital and School of Stomatology, Capital MedicalUniversity, No.9 Fanjiacun Road, Fengtai District, Beijing, 100070, China
1 shared publicationHockin H.K. Xu
Department of Biomaterials and Regenerative Dental Medicine, University of Maryland School of Dentistry, Baltimore, MD 21201, USA
1 shared publication- Jingyao Sun
College of Mechanical and Electrical Engineering Beijing University of Chemical Technology Beijing China
1 shared publication
Latest Publications
- 18 September 2026
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 33, 1-30
Therapeutic Effects of WIN55,212-2 on Temporomandibular Joint Osteoarthritis in a Rat Model and Primary Temporomandibular Joint Condylar Chondrocytes
Introduction/Objective: This study investigates the therapeutic potential of the synthetic cannabinoid WIN55,212-2 (WIN55) in temporomandibular joint osteoarthritis (TMJOA), focusing on its capacity to attenuate cartilage degradation and modulate inflammatory pathways, thereby providing preclinical evidence to support future clinical translation. Methods: A monosodium iodoacetate (MIA)-induced TMJOA model was established in rats, followed by WIN55 treatment. Cartilage integrity and subchondral bone structure were evaluated using histological and imaging techniques. Primary condylar chondrocytes were treated with IL-1β and WIN55 to elucidate the underlying inflammatory and molecular mechanisms through transcriptomic and protein-level analyses. Results: WIN55 significantly alleviated cartilage degradation in TMJOA, as evidenced by improved histological scores, preserved proteoglycan content, and maintained subchondral bone architecture. in vitro, WIN55 suppressed IL-1β-induced pro-inflammatory cytokines (e.g., Il-6, Tnf-α) and chemokines (e.g., Ccl2, Ccl5, Cxcl1). Transcriptomic analysis revealed that WIN55 reversed key inflammatory pathways, including TNF and IL-17 signaling, and downregulated IL-1β-induced colony-stimulating factors (Csf1, Csf2, Csf3). Additionally, WIN55 modulated the expression profiles of lncRNAs and circRNAs. Discussion: These findings provide the first comprehensive evidence that WIN55 exerts multi-target anti-inflammatory and chondroprotective effects in the TMJ context. By suppressing chemokine networks, CSF family members, and matrix-degrading enzymes while preserving extracellular matrix homeostasis, WIN55 addresses both inflammatory and degradative processes central to TMJOA pathogenesis. Modulation of non-coding RNAs suggests additional regulatory layers that may be exploited in future therapeutic strategies. Conclusion: WIN55 demonstrates significant therapeutic potential for TMJOA by mitigating cartilage degradation and modulating inflammatory responses. These findings highlight the promise of cannabinoid-based therapies for TMJOA and establish a foundation for subsequent clinical investigation.
- 18 September 2026
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 33, 1-30
Therapeutic Effects of WIN55,212-2 on Temporomandibular Joint Osteoarthritis in a Rat Model and Primary Temporomandibular Joint Condylar Chondrocytes
Introduction/Objective: This study investigates the therapeutic potential of the synthetic cannabinoid WIN55,212-2 (WIN55) in temporomandibular joint osteoarthritis (TMJOA), focusing on its capacity to attenuate cartilage degradation and modulate inflammatory pathways, thereby providing preclinical evidence to support future clinical translation. Methods: A monosodium iodoacetate (MIA)-induced TMJOA model was established in rats, followed by WIN55 treatment. Cartilage integrity and subchondral bone structure were evaluated using histological and imaging techniques. Primary condylar chondrocytes were treated with IL-1β and WIN55 to elucidate the underlying inflammatory and molecular mechanisms through transcriptomic and protein-level analyses. Results: WIN55 significantly alleviated cartilage degradation in TMJOA, as evidenced by improved histological scores, preserved proteoglycan content, and maintained subchondral bone architecture. in vitro, WIN55 suppressed IL-1β-induced pro-inflammatory cytokines (e.g., Il-6, Tnf-α) and chemokines (e.g., Ccl2, Ccl5, Cxcl1). Transcriptomic analysis revealed that WIN55 reversed key inflammatory pathways, including TNF and IL-17 signaling, and downregulated IL-1β-induced colony-stimulating factors (Csf1, Csf2, Csf3). Additionally, WIN55 modulated the expression profiles of lncRNAs and circRNAs. Discussion: These findings provide the first comprehensive evidence that WIN55 exerts multi-target anti-inflammatory and chondroprotective effects in the TMJ context. By suppressing chemokine networks, CSF family members, and matrix-degrading enzymes while preserving extracellular matrix homeostasis, WIN55 addresses both inflammatory and degradative processes central to TMJOA pathogenesis. Modulation of non-coding RNAs suggests additional regulatory layers that may be exploited in future therapeutic strategies. Conclusion: WIN55 demonstrates significant therapeutic potential for TMJOA by mitigating cartilage degradation and modulating inflammatory responses. These findings highlight the promise of cannabinoid-based therapies for TMJOA and establish a foundation for subsequent clinical investigation.
- Open Access
- 16 June 2025
- Published by Korean Association of Orthodontists in The Korean Journal of Orthodontics
- Vol. 55 (5) , 380-391
Comparative mechanical performance of thermoplastic materials for clear aligners under simulated oral conditions
Miao Liu, Yajie Wang, Ce Bian, Yang Han, Xuan Qin, Jingyao Sun, Yuxing Bai, Ning Zhang. Korean J Orthod 2025;55:380-91. https://doi.org/10.4041/kjod25.094
- 16 June 2025
- Published by Korean Association of Orthodontists in The Korean Journal of Orthodontics
- Vol. 55 (5) , 380-391
Open AccessComparative mechanical performance of thermoplastic materials for clear aligners under simulated oral conditions
Miao Liu, Yajie Wang, Ce Bian, Yang Han, Xuan Qin, Jingyao Sun, Yuxing Bai, Ning Zhang. Korean J Orthod 2025;55:380-91. https://doi.org/10.4041/kjod25.094
- 21 January 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 142, 104844
New generation of orthodontic devices and materials with bioactive capacities to improve enamel demineralization
- 21 January 2024
- Published by Elsevier in Journal of Dentistry
- Vol. 142, 104844
New generation of orthodontic devices and materials with bioactive capacities to improve enamel demineralization